Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.73 USD
Change Today -0.0268 / -3.56%
Volume 273.9K
BGMD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

bg medicine inc (BGMD) Key Developments

BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

BG Medicine, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. The company reported net loss for the second quarter of 2015 of $2.0 million, a 6% improvement from the $2.2 million net loss reported in the second quarter of 2014, on total revenues of $0.5 million in the second quarter of 2015 versus total revenues of $0.8 million in the second quarter of 2014. Net loss per basic and diluted share in the second quarter of 2015 was $0.23 as compared to $0.26 in 2014. Operating cash burn decreased by $1.8 million, a 68% decrease, to $827 thousand compared to $2.6 million in 2014. Loss from operations was $1.4 million compared to $2 million for the same period of last year. For the six months ended June 30, 2015, the company reported net loss of $3.4 million, a 22% improvement from the $4.3 million net loss reported for the six months ended June 30, 2014, on total revenues of $0.9 million versus total revenues of $1.5 million in the first six months of 2014. Net loss per basic and diluted share for the first six months of 2015 was $0.39 as compared to $0.56 in the first six months of 2014. Operating cash burn declined by $2.8 million, a 56% decrease, to $2.2 million compared to $5.0 million in 2014. Loss from operations was $2.7 million compared to $3.9 million for the same period of last year. Net cash flows from operating activities were $2.2 million compared to $5 million for the same period of last year.

BG Medicine, Inc. to Report Q2, 2015 Results on Aug 19, 2015

BG Medicine, Inc. announced that they will report Q2, 2015 results at 8:30 AM, US Eastern Standard Time on Aug 19, 2015

BG Medicine, Inc., Q2 2015 Earnings Call, Aug 19, 2015

BG Medicine, Inc., Q2 2015 Earnings Call, Aug 19, 2015

BG Medicine, Inc. Announces Payoff of Secured Term Loan

BG Medicine, Inc. announced that it has paid off its secured term loan facility with General Electric Capital Corporation and Comerica Bank. The secured term loan in the aggregate principal amount of $10 million was funded to BG Medicine in February 2012. BG Medicine has been making monthly principal and interest payments on this loan since August 2013. With payoff, all security interests that had been granted to the secured lenders are now released and discharged.

BG Medicine, Inc. Announces Amendment to the Certificate of Incorporation

BG Medicine, Inc. announced that at the AGM held on July 7, 2015, the shareholders approved amendment to the company's restated certificate of incorporation to effect a reverse stock split of the Company's common stock.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BGMD:US $0.73 USD -0.0268

BGMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $52.75 USD -0.21
BioMerieux €102.05 EUR +1.30
Laboratory Corp of America Holdings $119.61 USD -0.21
Quest Diagnostics Inc $68.89 USD -0.19
View Industry Companies
 

Industry Analysis

BGMD

Industry Average

Valuation BGMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BG MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.